New Results
A biosynthetic platform for antimalarial drug discovery
Mark D. Wilkinson, Hung-En Lai, Paul S. Freemont, View ORCID ProfileJake Baum
doi: https://doi.org/10.1101/814715
Mark D. Wilkinson
1Department of Chemistry, Imperial College London, UK
Hung-En Lai
2Department of Infectious Diseases, Faculty of Medicine, Imperial College London, UK
Paul S. Freemont
2Department of Infectious Diseases, Faculty of Medicine, Imperial College London, UK
Jake Baum
3Department of Life Sciences, Imperial College London, UK
Article usage
Posted October 22, 2019.
A biosynthetic platform for antimalarial drug discovery
Mark D. Wilkinson, Hung-En Lai, Paul S. Freemont, Jake Baum
bioRxiv 814715; doi: https://doi.org/10.1101/814715
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)